Targeted comparative proteomics by liquid chromatography/matrix-assisted laser desorption/ionization triple-quadrupole mass spectrometry

Here we report the first application of a matrix‐assisted laser desorption/ionization (MALDI) triple‐quadrupole mass spectrometer for targeted proteomics. Employing an amine‐specific isotopic labelling approach, the technique was validated using five randomly selected bovine serum albumin peptides d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Rapid communications in mass spectrometry 2006-03, Vol.20 (5), p.904-910
Hauptverfasser: Melanson, Jeremy E., Chisholm, Kenneth A., Pinto, Devanand M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Here we report the first application of a matrix‐assisted laser desorption/ionization (MALDI) triple‐quadrupole mass spectrometer for targeted proteomics. Employing an amine‐specific isotopic labelling approach, the technique was validated using five randomly selected bovine serum albumin peptides differentially labelled at known ratios. An indirect benefit of the isotopic labelling technique is a significant enhancement of the a1 ion in tandem mass (MS/MS) spectra of all peptides studied. Therefore, the a1 ion was selected as the fragment ion for multiple reaction monitoring (MRM) in all cases, eliminating tedious method development and optimization. Accurate quantification was achieved with an average relative standard deviation (RSD) of 5% (n = 5) and a detection limit of 14 amol. The technique was then applied to validate an important virulence biomarker of the fungal pathogen Candida albicans, which was not accurately quantified using global proteomics experiment employing two‐dimensional liquid chromatography/electrospray ionization tandem mass spectrometry (2D‐LC/ESI)‐MS/MS. Using LC/MALDI‐MRM analysis of five tryptic peptides, the protein PHR1 was found to be upregulated in the hyphal (pathogenic) form of C. albicans by a factor of 7.7 ± 0.8. Copyright © 2006 John Wiley & Sons, Ltd.
ISSN:0951-4198
1097-0231
DOI:10.1002/rcm.2391